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Beyond midlife, the immune system shows aging features and its defensive capability
becomes impaired, by a process known as immunosenescence that involves many changes
in the innate and adaptive responses. Innate immunity seems to be better preserved glob-
ally, while the adaptive immune response exhibits profound age-dependent modifications.
Elderly people display a decline in numbers of naïveT-cells in peripheral blood and lymphoid
tissues, while, in contrast, their proportion of highly differentiated effector and memory T-
cells, such as the CD28null T-cells, increases markedly. Naïve and memory CD4+ T-cells
constitute a highly dynamic system with constant homeostatic and antigen-driven prolifer-
ation, influx, and loss ofT-cells.Thymic activity dwindles with age and essentially ceases in
the later decades of life, severely constraining the generation of new T-cells. Homeostatic
control mechanisms are very effective at maintaining a large and diverse subset of naïve
CD4+ T-cells throughout life, but although later than in CD8+T-cell compartment, these
mechanisms ultimately fail with age.
Keywords: immunosenescence,T-cells, IL-15, inflammation, CMV, NKRs
INTRODUCTION
Throughout life the aging of the immune system causes impair-
ment of its defense capability, in a process known as immunose-
nescence. The aging process seems to alter the two branches of
the immune system, the innate and the adaptive, in different
ways. While the adaptive immune response undergoes profound
age-dependent modifications (Haynes and Maue, 2009), innate
immunity seems to be better preserved globally (Dace and Apte,
2008; Le Garff-Tavernier et al., 2010). The thymus, the develop-
ment site of T-cells, atrophies with age (Dorshkind et al., 2009),
with a direct impact on the proportions of naïve and memory T-
cells. In aged animals and humans, the frequency of naïve CD4+
T-cells decreases, whereas the frequency of memory CD4+ T-cells
increases (Nikolich-Zugich, 2005). Naïve and memory CD4+ T-
cells are clearly distinct populations with unique cellular character-
istics. Thus, any age-associated changes in CD4+ T-cell function
including proliferation and cytokine production could be sec-
ondary to the alteration in the frequency of naïve and memory
T-cells.
Despite CD4+ T-cells are more resistant to age-related phe-
notypic and functional changes than CD8+ T-cells (Weinberger
et al., 2007), a progressive increase in the percentage of CD4+
T-cells that lack CD28 expression is common with increasing
age in healthy individuals (Goronzy et al., 2007; Czesnikiewicz-
Guzik et al., 2008) and in patients with chronic infections and
autoimmune diseases (Fletcher et al., 2005; Thewissen et al., 2007).
The accumulation of CD4+CD28null T-cells is partially explained
by their reduced susceptibility to apoptosis and their oligoclonal
expansions against Cytomegalovirus (CMV) and other chronic
antigens (Almanzar et al., 2005; Pawelec and Derhovanessian,
2010). Loss of CD28 expression is a hallmark of the age-associated
decline of CD4+ T-cell function. CD28 plays pivotal roles dur-
ing T-cell activation, such as inducing cytokine production (IL-2)
and promoting cell proliferation, so the lack of this costimu-
latory signal during activation results in a partial activation or
even an anergic state of T-cells (Godlove et al., 2007). In this
way, the accumulation of CD28null T-cells is associated with a
reduced overall immune response to pathogens and vaccines in the
elderly (Saurwein-Teissl et al., 2002). In this way, CD4+CD28null
T-cells can comprise up to 50% of the total CD4+ T-cell compart-
ment in some individuals older than 65 years (Vallejo et al., 2000).
CD4+CD28null T-cells acquire expression of several receptors
commonly associated with natural killer (NK) cells, secrete large
amounts of IFN-γ, and express perforin and granzyme B, which
confer a cytotoxic capability on the cells (Appay et al., 2002b; van
Leeuwen et al., 2004).
CD4+ T-CELL DIFFERENTIATION
Naïve CD4+ T-cells are activated after interaction with the
antigen–major histocompatibility complex (MHC) complex and
differentiate into specific subtypes depending mainly on the
cytokine milieu of the microenvironment. The CD4+T-cells carry
out multiple functions, including activation of the cells of the
innate immune system, B-lymphocytes, cytotoxic T-cells, as well
as non-immune cells, and also play a critical role in suppressing the
immune reaction. With the advent of multiparameter flow cytom-
etry, it has become clear that individual cells can produce effector
cytokines in different combinations (Seder et al., 2008), raising
the question of whether there is heterogeneity within a lineage or
whether each distinct cytokine combination represents a separate
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lineage. Continuing studies have identified new subsets of CD4+
T-cells besides the classical T-helper 1 (Th1) and T-helper 2 (Th2)
cells. These include T-helper 17 (Th17), T-helper type 22 (Th22),
follicular helper T-cell (Tfh), induced T-regulatory cells (iTreg),
and the regulatory type 1 cells (Tr1) as well as the potentially dis-
tinct T-helper 9 (Th9). The differentiation of the various lineages
depends on the complex network of specific cytokine signaling
and transcription factors followed by epigenetic modifications.
The differentiation of naïve CD4+ T-cells into effector and
memory subsets is one of the most fundamental facets of T-cell-
mediated immunity. CD4+ T-cells can be separated into func-
tionally distinct populations using combinations of cell surface
markers, such as the tyrosine phosphatase isoform CD45RA+ and
the chemokine receptor CCR7 (Figure 1). With these markers, we
subdivided the T-cells into naïve (NAl¨VE; CD45RA+CCR7+),
central memory (CM; CD45RA−CCR7+), effector memory
(EM; CD45RA−CCR7-), and effector memory RA+ (EMRA;
CD45RA+CCR7-) cells (Sallusto et al., 1999). EM is a het-
erogeneous population, and the staining of two additional
markers, CD27 and CD28, has proved useful for identifying
the less differentiated EM1 (CD28+ and CD27+) and EM4
(CD28+ and CD27null) subsets, and the more differentiated
EM3 cells (CD27nullCD28null) (Figure 2). The EMRA subset
can be further subdivided into very poorly differentiated pE1
(CD27+CD28+) and the most highly differentiated T-cell sub-
set, E (CD27nullCD28null) (Koch et al., 2008) (Figure 2). Differen-
tiating CD4+ T-cells lose expression of CD27 first, then of CD28
in a later phase (Amyes et al., 2003; van Leeuwen et al., 2004). In
contrast, CD8+ T-cells lose expression of CD28 first and then of
CD27 (Gamadia et al., 2003).
NAÏVE CD4+ T-CELLS
Naïve T-cells are characterized by the expression of surface mark-
ers CD45RA, CD27, CD28, CD62L, CCR7, and the IL-7 receptor
(De Rosa et al., 2001; Swainson et al., 2006). Naïve T-cells exit
the thymus following maturation and are enriched for T-cell
receptor excision circles (TREC) and express the surface marker
CD31 (Kimmig et al., 2002). Naïve T-cells circulate between the
blood and the lymphoid tissue driven by cell surface markers
CD62L and CCR7 (Sallusto et al., 1999). The number of naïve
T-cells in the blood remains relatively constant throughout adult
life despite continuous stimulation with foreign antigens and a
dramatic reduction in thymic output with age. Although thymic
involution is a well-known phenomenon, no satisfactory explana-
tion for its existence has been offered (Lynch et al., 2009). Several
hypotheses have argued that this age-related change is adaptive
rather than detrimental (Aronson, 1991; O’Leary and Hallgren,
1991; Dowling and Hodgkin, 2009). Accordingly, thymic involu-
tion may represent a mechanism for how the body is able to achieve
the remarkable balancing act of avoiding autoimmunity and main-
taining a sufficiently diverse repertoire to combat a large number
of potential pathogens. Some possible causes of thymic involu-
tion may be the blocking of the rearrangement of T-cell receptor
(TCR) genes (Aspinall, 1997), self-peptide MHC-decreased mole-
cules (Lacorazza et al., 1999), and loss of T-cell progenitors (Zoller
et al., 2007). The importance of the thymus for developing ade-
quate cellular immunity can be studied in the context of several
FIGURE 1 | Distribution of CD4+T-cells into naïve, central memory,
effector memory (EM), and effector memory RA (EMRA). (A) Schematic
model of the T-cells differentiation subsets accordingly to CD4+5RA and
CCR7 expression. (B) Dot-plots representatives of the naïve, CM, EM, and
EMRA subsets in young people and elderly subjects into the CD4+T-cells.
Whole blood was stained with anti-CD45RA-FICT, anti-CD8-PE,
anti-CD4-PerCP, and anti-CCR7-APC, and 105 cells were acquired in each
experiment.
disease states (associated with thymic ablation or hypoplasia).
Young people who were thymectomized within 2 weeks of birth
display several immunological alterations, including lower CD4+
or CD8+ T-cell counts, reduced proportions of recent thymic
emigrants and naïve cells, accumulation of oligoclonal memory
T-cell populations, and increased levels of inflammation markers
(Sauce et al., 2009; Zlamy and Prelog, 2009).
Exposure to the cytokine IL-7 and contact with MHC mole-
cules presenting self-peptides through the TCR within secondary
lymphoid tissue are both essential for naïve T-cell homeosta-
sis (Brocker, 1997; Tan et al., 2001; den Braber et al., 2012).
When these naïve T-cells do encounter antigens on activated den-
dritic cells (DCs) in central lymphoid organs, they proliferate
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FIGURE 2 | Distribution of EM and EMRA in CD4+T-cells into
subsets defined by CD28 and CD27 expression. (A) Schematic model
of the EM and EMRA CD4+T-cells differentiation subsets accordingly to
CD27 and CD28 expression. EM T-cells can be divided into EM1
(CD27+CD28+), EM2 (CD27+CD28null, only in CD8+ T-cells), EM3
(CD27nullCD28null), and EM4 (CD27nullCD28+). Similarly, EMRA can be
divided into pE1 (CD27+CD28+) and pE2 (CD27+CD28null, only in
CD8 T-cells) and E (CD27nullCD28null). (B) Dot-plots representatives of the
EM and EMRA subsets in young people and elderly subjects into the
CD4+T-cells.
and differentiate into effector T-cells. When the antigen has been
cleared, a contraction phase follows, during which time the num-
ber of effector cells declines through apoptosis, leaving behind
some survivors that go on to differentiate into memory T-cells.
CENTRAL MEMORY
Human CM are CD45R0+ memory cells that constitutively
express CCR7 and CD62L, two receptors that are also character-
istic of naïve T-cells, and which are required for cell extravasation
through high endothelial venules (HEV) and migration to T-cell
areas of secondary lymphoid organs (Campbell et al., 1998; Forster
et al., 1999). Homeostatic proliferation ensures the longevity of
CM T-cells by inducing cell proliferation in the absence of cellular
differentiation or activation. This process is governed mainly by
IL-7. Nonetheless, CM T-cells can also be stimulated via engage-
ment of the TCR, leading to proliferation but also activation and
differentiation (Bosque et al., 2011). Compared with naïve T-cells,
CM have higher sensitivity to antigenic stimulation, are less depen-
dent on costimulation, and upregulate CD40L to a greater extent,
thus providing more effective stimulatory feedback to DCs and
B cells. Following TCR triggering, CM produce mainly IL-2, but
after proliferation they efficiently differentiate into effector cells
and produce large amounts of IFN-γ or IL-4.
EFFECTOR MEMORY
Human EM are memory cells that have lost the constitutive expres-
sion of CCR7, are heterogeneous for CD62L expression, and
display characteristic sets of chemokine receptors and adhesion
molecules that are required for homing to inflamed tissues. Com-
pared with CM, EM cells are characterized by a rapid effector
function. They produce IFN-γ, IL-4, and IL-5 within hours of
antigenic stimulation. The relative proportions of CM and EM in
blood vary in the CD4+ and CD8+ T-cells. CM is predominant
in CD4+ and EM in CD8+ (Taylor and Jenkins, 2011). Within the
tissues, CM cells are enriched in lymph nodes and tonsils, whereas
lung, liver, and gut contain greater proportions of EM (Camp-
bell et al., 2001). Increasing evidence indicates the existence of
highly heterogeneous functional EM subpopulations: EM1, which
is very similar to EM4, and EM3. EM1 and EM4 are memory-like,
and EM3 is effector-like. Taken together, these data are consistent
with the model according to which there is a differentiation path-
way with progressive loss of CCR7, CD27, and CD28 cell surface
expression concomitant with upregulation of cytolytic capacity
(Appay et al., 2002a).
EFFECTOR MEMORY RA
Persistent viral infections and inflammatory syndromes induce the
accumulation of T-cells with characteristics of terminal differen-
tiation or senescence. However, the mechanism that regulates the
end-stage differentiation of these cells is unclear. EMRA T-cells
have features of telomere-independent senescence that are regu-
lated by active cell signaling pathways that are reversible. These
EM T-cells that re-express CD45RA (CCR7-CD45RA+; EMRA)
have many characteristics of end-stage differentiation. The EMRA
subset can be further subdivided into very poorly differentiated
pE1 (CD27+CD28+) and the most differentiated T-cell subset,
E (CD27nullCD28null). However, the exact nature of these T-cells
is not clear.
PHENOTYPIC AND FUNCTIONAL CHANGES ASSOCIATED
WITH AGING
As we age, the CD4+ T-cells are repetitively stimulated by a large
number of different antigens and as a consequence, CD4+ T-cells
become refractory to telomerase induction, suffer telomere ero-
sion, and enter replicative senescence. Replicative senescence is
characterized by the accumulation of highly differentiated T-cells
with newly acquired functional capabilities, which can be caused
by aberrant expression of genes normally suppressed by epigenetic
mechanisms in CD4+ T-cells. Age-dependent demethylation and
overexpression of genes normally suppressed by DNA methylation
have been demonstrated in senescent subsets of T-lymphocytes
(Lu et al., 2003; Liu et al., 2009). There are some major features
of CD4+ T-cell that are acquired as they age: loss of proliferative
capacity and telomerase activity, TCR restriction, low production
of and response to IL-2, high response to IL-15, loss of expres-
sion of CD28 molecule, expression of NK cell-related receptors
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Table 1 | Functional differences between naïve and late-memory CD4+
T-cells.
Naïve CD4+ Late-memory
↑↑↑ Proliferative capacity ↓↓
↑↑↑ Telomerase activity ↓↓
– TCR restriction ↑↑
↑↑↑ IL-2 production and response ↓↓
– Response to IL-15 ↑↑
↑↑↑ CD28 expression ↓↓
– NKRs ↑↑
↑↑ IFN-γ production ↑↑↑
– Cellular cytotoxicity (perforin and granzyme) ↑↑
(NKRs), production of molecules involved in cellular cytotoxi-
city (perforin and granzyme), and a substantial increase in the
production of IFN-γ (Appay et al., 2008) (Table 1).
THE COSTIMULATORY MOLECULE CD28 IN AGED CD4+ T-CELL
Several studies have demonstrated that expression of TCR in
CD4+ T-cells are not altered in the elderly (Bazdar et al., 2009),
however, costimulatory molecules required for lymphocyte acti-
vation appear to be altered. One of the major costimulatory
molecules present in T-lymphocytes is the CD28 molecule, and
its loss as individuals age is well-documented in CD4+ T-cells
(Weyand et al., 1998). Loss of CD28 has been associated with a loss
of immune system responsiveness in the elderly. These cells are less
able to proliferate than are CD4+CD28+ T-cells, have a dimin-
ished antigenic recognition repertoire, and gain a very powerful
cytotoxic capacity (Bryl and Witkowski, 2004). CD28 downreg-
ulation occurs with T-cell activation, involving transcriptional
repression and increased protein turnover. This is thought to be a
negative feedback mechanism (Swigut et al., 2001). When CD4+
T-cells recognize an antigen, CD28 expression decreases rapidly,
but immediately returns to normal levels. However, with sustained
stimulation over time, the expression of CD28 decreases and may
be lost. CD28 can be initially reinduced by IL-12 (Warrington
et al., 2003) or with treatment with anti-TNF agents (Rizzello
et al., 2006), but once firmly established, its loss is irreversible in
the majority of CD28null T-cells, suggesting active transcriptional
silencing.
ACQUISITION OF NEW AGING MARKERS
Although CD28 is a major costimulatory molecule, these CD28null
T-cells remain functionally active; other molecules must be able
to maintain responsiveness and survival in these cells. Therefore,
alternative receptors must exist to prevent these cells entering into
a state of anergy. CD4+CD28null T-cells are resistant to apoptosis
(Vallejo et al., 2000), which is one possible cause of its accumula-
tion throughout life (Posnett et al., 1994). An explanation of why
these cells are able to be activated, is the de novo expression of
several NKRs (Abedin et al., 2005). Among the best studied are
the receptors CD16, CD56, CD94, KLRG1, several members of the
NK receptor G2 (NKG2), and the killer cell immunoglobulin (Ig)-
like receptor (KIR) families. CD94, KLRG1, and the NKG2s are
lectin-like receptors, and CD16 and CD56 are receptors belonging
to the superfamily of immunoglobulins, and are the prototypic
NKRs that are normally used to identify NK cells (Figure 3). The
functional roles of CD16, CD56, and CD94 on senescent T-cells
are still unknown. The KLRG1 receptor seems to influence the
state of CD4+ T-cell senescence due to their ability to inhibit
proliferation via TCR (Hayhoe et al., 2010; Di Mitri et al., 2011).
KLRG1 contains an immunoreceptor tyrosine-based inhibitory
motif (ITIM) in its cytoplasmic domain and has been shown to
be a receptor for some members of the cadherin family of pro-
teins (Grundemann et al., 2006). It is an inhibitory receptor and its
presence in CD4+T-cells blocks the costimulatory activities medi-
ated by Akt, such as proliferation (Henson et al., 2009). Among
NKG2s receptors, only NKG2D is expressed in CD4+CD28null
aged T-cells, its expression becoming present for the first time
in CD4+CD28null T-lymphocytes as people age. This novel age-
marker was recently described by our laboratory (Alonso-Arias
et al., 2011b). It has been implicated in NK-mediated anti-viral
immunity and in TCR-independent cytotoxic activity in CD4+
and CD8+ T-cells. The regulation of KIRs seems to differ in NK
cells and T-lymphocytes (Xu et al., 2005). The KIR repertoire in
T-cells is very restricted (Abedin et al., 2005), being limited to
memory T-cells, mainly CD28null T-lymphocytes. In addition, the
same population of T-lymphocytes with the same TCR specificity
may have different combinations of KIRs on their surface (Vely
et al., 2001; van Bergen et al., 2009). It seems quite clear that the
expression of NKRs differs in oligoclonal and senescent T-cells.
The expression of these molecules appears to represent a different
way of diversifying the immune repertoire, i.e., an oligoclonal pop-
ulation of T-lymphocytes for a particular TCR can express a wide
diversity of receptor NKRs codominantly (Tarazona et al., 2000)
(Figure 3). In the case of arterial disease and CMV infection, the
expression of KIR receptors in CD4+CD28null T-cells is broadly
accepted as being responsible for their functionality (Zal et al.,
2008; van Bergen et al., 2009). The appearance of these “aberrant”
molecules in senescent T-cells could help maintain the adequate
homeostasis of T-cells and would be a way to stay functionally
active, independent of TCR activation.
FUNCTIONAL PROPERTIES ACQUIRED BY AGING CD4+ T-CELLS
A defining feature of the eukaryotic genome is the presence of lin-
ear chromosomes. This arrangement, however, poses several chal-
lenges with regard to chromosomal replication and maintenance.
Telomeric DNA is lost due to the incomplete terminal synthesis of
the lagging DNA strand during cell division. Immune cells must
be able to grow exponentially and die when no longer needed.
They support an extremely high replicative rate, so their telomeres
suffer great stress. The lymphocytes are capable of upregulating
telomerase, an enzyme that elongates telomeres and can therefore
prolong the life of the cell (Klapper et al., 2003; Andrews et al.,
2010). Signaling via the TCR and other costimulatory molecules,
such as CD28, are necessary for inducing telomerase activity with
a peak of activation at 4–5 days after stimulation and a decrease in
activity at 10 days (Macallan et al., 2004; Fritsch et al., 2005). In the
absence of mechanisms that compensate for telomere shortening,
growth arrest of the cells occurs when progressive telomere erosion
reaches a critical point known as replicative senescence (Hodes
et al., 2002). The overall finding from several different studies is
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FIGURE 3 | Older people present a different receptor repertoire from that
of young individuals. Despite the decline of thymic function and the low
TCR diversity, the elderly CD4+T-cells present novel functions attributed to
their acquisition of NK-related receptors (NKRs) such as KIR, CD94, CD16,
CD56, NKG2, and KLRG1. CD4+T-cells undergo senescence due to lifetime
exposure to persistent pathogens and to homeostatic proliferation. With
advancing age, the T-cell repertoire becomes populated with highly
oligoclonal, long-lived T-cells, most of which have lost the ability to express
CD28. Such CD28null T-cells have limited proliferative capacity, but are
functionally active. They are generally long-lived and functionally active.
that human T-cells can undergo a limited number of divisions,
after which they cease dividing (Perillo et al., 1989). Importantly,
the arrival of T-cells at a stage of replicative senescence does not
imply the loss of cell viability. In fact, under appropriate condi-
tions senescent cells remain alive and metabolically active for a long
period (Wang et al., 1994). In cultures where CD4+ and CD8+
T-cells of the same subject are stimulated identically, CD8+T-cells
were unable to upregulate telomerase after the fourth encounter
with the antigen. In contrast, the CD4+ T-cells from the same
donor had a high level of telomerase activity induced by anti-
gen (Valenzuela and Effros, 2002). Several studies have shown
that telomerase activity is preserved and replicative senescence
is delayed if telomere length is stabilized (Dagarag et al., 2004;
Choi et al., 2008). The inhibition of cytokines involved in short-
ening telomeres, such as TNF-α, could delay telomeric loss. One
of the main causes of cell division is the interaction of TCR and
CD28 receptors that leads to the production of cytokines. One of
the best studied is IL-2, which is produced in an autocrine form
and that causes upregulation of its own receptor (IL-2R), com-
posed of three subunits (α, β, and γ) (Almeida et al., 2002). The
γ-chain is common to other cytokine receptors such as IL-7, IL-
15, and IL-21, and the differences in the responses elicited by these
cytokines must lie in the other two chains that form the recep-
tor. The main molecules involved in signaling via IL-2 are Janus
kinases (Jaks) and signal transducer and activator of transcription
(STATs) (Johnston et al., 1996). One of the first indications that
the immune system of the elderly has impaired functionality was
the reduction in the production of IL-2 (Caruso et al., 1996). Sev-
eral studies have demonstrated that levels of TCR in T-cells are
not altered in the elderly, for which reason it is thought that the
problem may be to do with intracellular signaling (Bazdar et al.,
2009). Alterations in intracellular signaling may partly explain the
lack of production of IL-2 in the elderly.
CD4+ T-cells have not been classically considered as cytotoxic
cells, although intracytoplasmic stores of granzyme B and perforin
have been previously described in CD4+CD28null T-cells (Appay
et al., 2002b). Granzyme B and perforin expression in CD4+ T-
cells are closely associated with the loss of CD28 from the cell
surface. These CD4+CD28null T-cells resemble cytotoxic CD8+
T-cells, because their cytotoxic capacity is mediated by TCR stimu-
lation. In addition, they lack costimulatory molecule requirements
(Appay et al., 2002a). The expression of NK molecules described
above is associated with increased cytotoxic capacity with high
levels of expression of intracytoplasmic perforin and granzyme
(Brown et al., 2012). The expression of these NK receptors in
CD4+ T-cells probably serves to regulate their cytotoxicity, and
even cytokines involved in NK cell activation, such as IL-15, can
enhance their cytotoxic ability. The expansion of these cells not
only occurs in the elderly, but also under other clinical conditions
involving chronic activation of the immune system, such as viral
infections, autoimmune and rheumatic diseases, certain tumors,
and coronary artery disease (Thewissen et al., 2007; Alonso-Arias
et al., 2009). CD4+CD28null T-cells also secrete large amounts
of IFN-γ. CD4+CD28null T-lymphocytes have been described as
being antigen-specific cells against chronic viral antigens, mainly
in some autoimmune diseases (Thewissen et al., 2007). IFN-γ
expression is present at all stages of CD4+ T-cell differentiation,
but is mostly improved in late-differentiated cells that lack IL-2-
production (Yue et al., 2004; Harari et al., 2005). The dominant
IFN-γ CD4+ T-cell response is associated with models of antigen
persistence and high antigen levels.
It has been hypothesized that CD4+CD28null T-cells might
play a role in containing viral infections tropic for HLA class II
cells, such as EBV in B cells, HIV-1 in activated CD4+ T-cells,
monocytes and DCs, and CMV in endothelial cells. However, the
presentation mechanism of this antigen is not currently known.
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In the case of CMV infection, endothelial cells are poor antigen-
presenting cells under normal conditions in a classical immune
response because they lack costimulatory molecules. Nevertheless,
since the CD28null T-cells do not require costimulation and have a
low activation threshold, antigen presentation could be rendered
effective by non-professional cells such as endothelial cells. This
hypothesis is supported by the fact that the class II pathway may
be preferentially targeted, since both EBV and CMV prevent nor-
mal MHC class I expression as part of their strategies of immune
evasion (Alcami and Koszinowski, 2000).
IMMUNE FUNCTIONAL (DIS)ABILITY
The human immune system progressively deteriorates with age,
leading to a greater incidence or the reactivation of infectious
diseases, as well as to the development of autoimmune disorders
and cancer (DelaRosa et al., 2006; Prelog, 2006). These defective
immune responses are also manifested in a reduced capacity to
induce immunological memory to vaccines and infections. In fact,
the incidence of acute transplantation rejections is significantly
lower in elderly transplant patients (Bradley, 2002; Deng et al.,
2004; Trzonkowski et al., 2010). Immunological impairment may
be partially due to the restriction of antigen recognition (Figure 3).
Protection from pathogens and tumor development depends on
the generation and maintenance of a diverse TCR repertoire.
CD4+ and CD8 T-cells undergo the same principal phenotypic
shifts; however, the rate at which they occur or accumulate with
age is vastly different. Diminution of naïve cells with age is drastic
for CD8 T-cells, but relatively minor for CD4+ T-cells. Home-
ostatic control of the CD4+ compartment is much more robust
than that of CD8 T-cells. In spite of the majority of naïve T-cells
in the adult being generated by IL-7- and IL-15-induced division
of pre-existing cells, the diversity of the naïve CD4+ T-cell reper-
toire is maintained up to the age of 65 years (Prlic and Jameson,
2002; Naylor et al., 2005). At older ages, TCR diversity is remark-
ably reduced by accumulation of clonal cells in both naïve and
memory compartments (Vallejo, 2007). Elderly donors display a
marked increase in the proportion of highly differentiated effector
and memory T-cells due to a lifetime of exposure to a variety of
pathogens. Accumulation of these highly differentiated T-cells is
partially explained by their reduced susceptibility to apoptosis and
their oligoclonal expansions against CMV and other chronic anti-
gens (Vescovini et al., 2004; Almanzar et al., 2005; Vasto et al., 2007;
Derhovanessian et al., 2009). Persistent viral infections and/or
the pro-inflammatory cytokines produced during some infectious
processes may drive their differentiation. Another possible expla-
nation is the corroborated fact that advanced age is accompanied
by low-grade, chronic upregulation of inflammatory responses,
evidence for which is provided by increased serum levels of pro-
inflammatory cytokines (IL-6, IL-15, IL-8), coagulation factors,
and reactive oxygen species (ROS) (Mari et al., 1995; Forsey et al.,
2003; Zanni et al., 2003; Ferrucci et al., 2005; Wikby et al., 2006;
Giunta et al., 2008). Since the number of circulating T-cells is
maintained over the lifespan, a compensatory mechanism may
give rise to an increase in highly differentiated memory cells in
parallel with the reduction in naïve cell proliferation. Even the
higher absolute counts of highly differentiated CD8+T-cells could
modulate the levels of CD4+ T-cells. Experienced T-lymphocytes,
mainly CD8+, may fill the immunological space, and homeostatic
mechanisms block the generation of new naïve cells to maintain
the numbers of peripheral T-lymphocytes (Alonso-Arias et al.,
2013). These mechanisms make it difficult to preserve the T-cell
repertoire diversity that combats new pathogens and the host’s
ability to mount vigorous recall responses to recurrent infections
(Nikolich-Zugich, 2008). Another of the most prominent changes
during T-cell aging in humans is the change in the functional abil-
ity of the T-cells with a high degree of differentiation. CD28 is
pivotal in T-cell activation, doing such things as inducing cytokine
production (IL-2) and promoting cell proliferation, so the lack of
this costimulatory signal during activation results in a partial acti-
vation or even an anergic state of T-cells (Godlove et al., 2007). In
contrast, CD4+CD28null T-cells have a low activation threshold,
which could play a part in their predisposition to the breakage of
self-tolerance (Yung et al., 1996). In this way, the accumulation
of CD28null T-cells, particularly within the CD8 subset, is associ-
ated with a reduced overall immune response to pathogens and
vaccines in the elderly (Saurwein-Teissl et al., 2002; Alonso-Arias
et al., 2013).
EFFECT OF IL-15 HOMEOSTATIC CYTOKINE ON HIGHLY
DIFFERENTIATED CD4+ T-CELLS
It is widely accepted that IL-7 signaling through the IL-7 recep-
tor (IL-7R), is essential for prolonged survival and proliferation
of naïve and memory T-cells. Naïve T-cells rely on survival sig-
nals through contact with self-peptide-loaded MHC molecules
plus interleukin IL-7. On the other hand, antigen-experienced
(memory) T-cells are typically MHC-independent and survive
and undergo periodic homeostatic proliferation through contact
with both IL-7 and IL-15 (Boyman et al., 2012) (Figure 4). Both
cytokines seem equally essential to enable these cells to undergo
basal homeostatic proliferation (Lenz et al., 2004; Purton et al.,
2007), but IL-15 has a less prominent role for memory CD4+
cell homeostasis than for NK and memory CD8+ cells (Surh and
Sprent, 2008). Memory CD4+ T-cells compete less effectively for
IL-15 than the latter cells since they have much lower levels of
expression of the IL-15 receptor (Lenz et al., 2004). Homeosta-
tic proliferation of T-cells can be one cause of the age-associated
loss of CD28 expression, since CD8+ memory T-cells in the
presence of IL-15 alone, without TCR stimulation, lose CD28
expression and proliferate at a similar rate to CD8+CD28+ T-
cells (Chiu et al., 2006). In contrast, IL-15 does not induce loss of
CD28 expression in CD4+ T-cells, although recent studies have
shown that IL-15 does in fact play an appreciable role in CD4+
memory T-cell proliferation under physiological conditions and
after in vitro stimulation (Geginat et al., 2001; Lenz et al., 2004;
Alonso-Arias et al., 2011b) (Figure 4). CD4+ memory T-cells
rely on STAT5, the downstream signaling molecule used by IL-
15, considerably more than do effector CD4+ T-cells (Purton
et al., 2007; Tripathi et al., 2010). IL-15 increased the cytolytic
properties of CD4+CD28null T-cells and enhanced their antigen-
specific responses (Alonso-Arias et al., 2011b). Although the role
of CD4+ T-cells as cytotoxic effector cells is not well understood,
the enhancing effector activity of IL-15 may have a substantial
impact, since CD4+CD28null T-cells are mainly specific against
chronic contact antigens. Moreover, IL-15 plays a critical role in
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FIGURE 4 | Effect of IL-15 homeostatic cytokine on CD4+T-cells.
(A) It is widely accepted that IL-7 signaling through the IL-7 receptor is
essential for prolonged survival of naïve and memory T-cells. Naïve T-cells
rely on survival signals through contact with self-peptide-loaded major
histocompatibility complex (MHC) molecules plus interleukin IL-7. (B)
Antigen-experienced (memory) T-cells are typically MHC-independent.
They survive and undergo periodic homeostatic proliferation through
contact with both IL-7 and IL-15. (C) IL-15 promotes the proliferation of
late-memory CD4+T-cells and enhances the proliferative response of
CD28null cells with respect to CD28+ CD4+T-cells. IL-15 increases the
cytolytic properties of CD4+CD28null T-cells and enhances their
antigen-specific responses.
the immune responses to early infection and chronic inflamma-
tion by amplifying the effects of pro-inflammatory cytokines on
IFN-γ secretion and by enhancing the antigen-specific responses
of CD4+CD28null (Smeltz, 2007; Alonso-Arias et al., 2011b).
INFLAMMATION AND CMV AS INDUCTORS OF CD4+ T-CELL
AGING
The degree of immunosenescence varies greatly, even among age-
matched elderly individuals (Alonso-Arias et al., 2011a). This may
mean that individual or environmental factors influence immuno-
logical status in different ways. In younger individuals, the inflam-
matory response is necessary to protect against infectious and
damaging agents, but it can be detrimental in later life (Franceschi
et al., 2007). As a result of continual antigenic stress through-
out life, chronic low-grade inflammation develops, and this is
considered to be a major contributor to age-associated frailty, mor-
bidity, and mortality (Franceschi et al., 2000). Progressive T-cell
differentiation and low-grade inflammation are two processes that
occur simultaneously and/or enhance each other. Highly differen-
tiated cells help increase the levels of pro-inflammatory cytokines,
whereas inflammatory mediators are involved in the development
of differentiated T-cell phenotypes. The ability to prevent or block
this inflammatory status may be responsible for the differences
seen between individuals. In centenarians, who are commonly
considered a paradigm of “successful aging,” the chronic pro-
inflammatory state of aging is countered by increased expression
of anti-inflammatory cytokines. In this way, the frequency of the
IL-10 (−1082GG) genotype, associated with increased produc-
tion of this anti-inflammatory cytokine, is higher in centenarians
than in younger controls (Lio et al., 2004). In parallel, their
immune system exhibits no signs of a T-cell Immune Risk Pro-
file (IRP), comprising a group of immune parameters which has
been defined as an inverted CD4/CD8 ratio, an accumulation of
CD8+CD28null T-cells, and CMV infection (Olsson et al., 2000).
The inverted CD4/CD8 ratio was the sole marker significantly
associated with the IRP. Subsequently, CMV infection has been
shown to exert a major impact on the immunosenescence process
(Hadrup et al., 2006). The Swedish OCTO and NONA immune
longitudinal studies were able to identify and confirm the IRP
predictive of an increased 2-year mortality in very old individuals,
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86–94 years of age. Recently, a similar study conducted in sub-
jects aged 66, indicates that the IRP could be also associated with
increased mortality in hexagenerians. Therefore, it will be impor-
tant to examine morbidity and mortality to assess whether the
immune profile also is an IRP in the hexagenerians (Strindhall
et al., 2012).
One of the main factors affecting longevity could be repre-
sented by a well-functioning immune system that prevents the
main age-related chronic diseases such as atherosclerosis, type
2 diabetes, and Alzheimer’s disease (Pradhan et al., 2001; Libby
et al., 2002; Griffin, 2006). Even depression and frailty (the lat-
ter an emerging clinical entity occurring late in life), which are
correlated with increased morbidity and mortality within a few
years, have a major inflammatory component (De Martinis et al.,
2006; Raison et al., 2006). These pathologies are all also character-
ized by important alterations in the CD4+ T-cell compartment,
resulting in lower proportions of naïve cells and higher propor-
tions of late-differentiated cells (Dumitriu et al., 2009; Giubilato
et al., 2011; Pellicano et al., 2012). Recently, CMV has been linked
to this range of chronic diseases with an inflammatory compo-
nent (Harkins et al., 2002; Aiello et al., 2006; Simanek et al., 2009;
Moro-Garcia et al., 2012). The specific mechanisms responsible
for these associations are not fully determined but are likely to
have an inflammatory and immune component. After infection,
the virus establishes lifelong latency within the host and period-
ically reactivates. Reactivation from latency is a key step in the
pathogenesis of the infection and can be detected in response
to inflammation, infection, stress, or immunosuppression (Kutza
et al., 1998; Prosch et al., 2000). Activation of protein kinase C and
NF-κB by TNF-α and increasing concentrations of cyclic AMP
by stress hormones and prostaglandins promotes viral reactiva-
tion and replication. Reactivation of CMV is more frequent in
the elderly and the virus, in turn, may result in increased levels of
pro-inflammatory molecules such as IL-6, TNF-α, and C-reactive
protein (CRP) (Stowe et al., 2007), contributing to the increase
in the inflammatory status. These more frequent and/or intense
reactivations in the elderly may be a consequence rather than the
cause of immunosenescence. Furthermore, reactivations imply
repetitive reencounters between specific T-cells and CMV anti-
gens, leading to their activation and proliferation and consequent
aging.
Despite the evidence suggesting that CMV induces aging of T-
lymphocytes, more frequent and/or intensive reactivations in the
elderly may be a consequence rather than the cause of immunose-
nescence. CMV seropositivity and anti-CMV antibody titers are
related to the degree of differentiation of CD4+ T-cells and
to the other IRP parameters of elderly people (Olsson et al.,
2000; Alonso-Arias et al., 2013). Differences between elderly and
young individuals in highly differentiated and naïve CD4+ T-cells
become more marked, depending on their anti-CMV antibody
titers.
Strategies directed at counteracting the inflammatory status
in the elderly have been evaluated. Cross-sectional studies reveal
an association between physical inactivity and low-grade systemic
inflammation in elderly people (Wannamethee et al., 2002; King
et al., 2003). Sedentary elderly individuals have a greater risk of
mortality than those doing intermediate or high levels of phys-
ical activity, who have a reduced risk of coronary heart disease,
neurodegeneration, cancer incidence, and disability (functional
impairment) (Hambrecht et al., 2000; Melzer et al., 2004; Lauten-
schlager et al., 2011; Speelman et al., 2011). Elderly individuals
with functional disability, which implies mobility impairment,
even to the point of not being able to perform all daily activities
adequately, also have smaller naïve CD4+ T-cell subpopulations
and higher percentages of effector cells, together with reduced
anti-CD3 responses. However, their responses to CMV gradually
increase. The underlying mechanisms conferring protection are
not known but it is thought that the anti-inflammatory role of
moderate physical activity may be an influence (Pedersen and
Saltin, 2006; Walsh et al., 2011; Warren et al., 2011). This anti-
inflammatory effect of exercise may be responsible for the benefi-
cial effects of exercise on health, and may play important roles in
the protection against aging of the immune response and diseases
associated with low-grade inflammation.
CONCLUDING REMARKS
Changes similar to those observed in CD8+ T-cells during
aging appear, albeit belatedly, in the compartment of CD4+ T-
lymphocytes. These aged CD4+T-cells can be found in the elderly
and in individuals under inflammatory and/or antigenic stress due
to autoimmune or chronic infectious processes. All these events
in CD4+ T-cells appear at late stages in life, correlating with the
impaired health status in elderly people. This impairment may be
the result of their restricted immune response, as reflected by their
reduced ability to fight against pathogens and poorer response to
vaccination. A possible field of action to prevent the deterioration
of the adaptive immune response would be the “rejuvenation” of
the CD4+T-cell population. Preclinical and clinical studies on the
T-cell reconstitution effects of sex steroid ablation, keratinocyte
growth factor, the growth hormone pathway, and the cytokines
IL-7, IL-12, and IL-15 indicate that these strategies may be used
to alleviate the effects of T-cell deficiencies in the aging immune
system.
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